Candriam S.C.A. Purchases 151,988 Shares of Cardinal Health, Inc. $CAH

Candriam S.C.A. lifted its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 607.5% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 177,008 shares of the company’s stock after purchasing an additional 151,988 shares during the quarter. Candriam S.C.A.’s holdings in Cardinal Health were worth $29,739,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of CAH. Counterpoint Mutual Funds LLC bought a new position in shares of Cardinal Health during the second quarter valued at about $1,911,000. Atlantic Union Bankshares Corp purchased a new stake in Cardinal Health during the 2nd quarter valued at about $79,000. KLP Kapitalforvaltning AS grew its position in Cardinal Health by 4.0% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 114,198 shares of the company’s stock worth $19,185,000 after acquiring an additional 4,400 shares during the last quarter. Czech National Bank grew its position in Cardinal Health by 5.1% during the 2nd quarter. Czech National Bank now owns 58,341 shares of the company’s stock worth $9,801,000 after acquiring an additional 2,857 shares during the last quarter. Finally, Zurich Insurance Group Ltd FI increased its stake in Cardinal Health by 4,935.9% in the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock worth $130,434,000 after purchasing an additional 927,950 shares during the period. Institutional investors own 87.17% of the company’s stock.

Analysts Set New Price Targets

CAH has been the subject of several analyst reports. Leerink Partners increased their price target on shares of Cardinal Health from $187.00 to $211.00 in a research report on Friday, October 31st. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. Robert W. Baird set a $232.00 price target on Cardinal Health in a research report on Friday, October 31st. Finally, Citigroup lifted their price objective on Cardinal Health from $165.00 to $190.00 and gave the stock a “neutral” rating in a research report on Friday, October 31st. Twelve research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $205.00.

Cardinal Health Price Performance

CAH stock opened at $205.94 on Friday. Cardinal Health, Inc. has a 1 year low of $114.60 and a 1 year high of $207.47. The firm has a 50-day moving average of $164.46 and a 200 day moving average of $158.49. The company has a market cap of $48.93 billion, a P/E ratio of 31.93, a PEG ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. During the same quarter in the prior year, the business earned $1.88 EPS. The business’s revenue for the quarter was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s dividend payout ratio is presently 30.77%.

Insiders Place Their Bets

In related news, insider Ola M. Snow sold 28,151 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the transaction, the insider directly owned 15,431 shares in the company, valued at $2,298,293.14. This trade represents a 64.59% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the transaction, the insider directly owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 271,676 shares of company stock valued at $40,489,525 in the last 90 days. Corporate insiders own 0.12% of the company’s stock.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.